Stock CYADY CELYAD ONCOLOGY SA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Celyad Oncology SA OTC Markets

Equities

CYADY

US1512052002

Biotechnology & Medical Research

Business Summary

Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T candidates in solid tumors and hematological malignancies.

Number of employees: 18

Sales per Business

EUR in Million2022Weight2023Weight Delta
Cardiology
100.0 %
0 nan % 0 100.0 % -

Sales per region

EUR in Million2022Weight2023Weight Delta
Europe and United States
100.0 %
0 nan % 0 100.0 % -

Managers

Managers TitleAgeSince
Michel Lussier FOU
 Founder 67 07-07-23
David Georges DFI
 Director of Finance/CFO - 18-12-31
Eytan Breman CTO
 Chief Tech/Sci/R&D Officer - 14-12-31
An Phan LAW
 General Counsel 49 21-08-31

Members of the board

Members of the board TitleAgeSince
Michel Lussier FOU
 Founder 67 07-07-23
Hilde Windels CHM
 Chairman 59 18-05-06
Serge Goblet BRD
 Director/Board Member - 07-12-31
J. Christopher LiPuma BRD
 Director/Board Member 53 22-01-19
Jonathan M. James BRD
 Director/Board Member - -
Dominic Piscitelli BRD
 Director/Board Member 50 20-05-05
Sage Mandel BRD
 Director/Board Member - -
Marina Udier BRD
 Director/Board Member - 11-01-10
Ami Patel Shah BRD
 Director/Board Member - 21-12-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 41,428,572 38,267,083 ( 92.37 %) 0 92.37 %

Shareholders

NameEquities%Valuation
Tolefi SA
5.541 %
2,295,701 5.541 % 757 627 $
Michel Lussier
0.3779 %
156,550 0.3779 % 51 665 $
BNP Paribas Asset Management Belgium SA
0.1753 %
72,641 0.1753 % 23 973 $
Serge Goblet
0.1356 %
56,180 0.1356 % 18 541 $
Gestys SA
0.0676 %
28,000 0.0676 % 9 241 $

Company contact information

Celyad Oncology SA

Axis Business Park Rue André Dumont 9

1435, Mont-Saint-Guibert

+32 1 039 41 00

http://www.celyad.com
address Celyad Oncology SA(CYADY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+17.72% 44.87B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-10.33% 37.8B
LONZA GROUP AG Stock Lonza Group AG
+42.15% 37.61B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+29.36% 31.32B
CELLTRION, INC. Stock Celltrion, Inc.
-8.44% 27.4B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+12.45% 26.32B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+44.19% 14.07B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.93% 12.5B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-7.67% 11.23B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CYAD Stock
  4. CYADY Stock
  5. Company Celyad Oncology SA